Alumis Inc. (ALMS) — Insider Activity & Signal

Healthcare · Biotechnology · Market cap $1.1B · $9.22 · 52-week range $3.76–$31.35

Recent insider buying

Open-market purchases reported to the SEC (last six months). Option grants and tax-withholding sales are excluded.

Date	Insider	Role	Shares	Price	Value	Source
2026-09-08	AKKARAJU SRINIVAS	director	273,291	$10.63	$2,904,291	SEC Form 4
2026-09-08	AKKARAJU SRINIVAS	director	273,290	$10.63	$2,904,280	SEC Form 4
2026-09-04	AKKARAJU SRINIVAS	director	220,070	$11.17	$2,458,842	SEC Form 4
2026-09-04	AKKARAJU SRINIVAS	director	220,070	$11.17	$2,458,842	SEC Form 4

Financial health

Altman Z-Score 1.78 · Piotroski F-Score 2/9 · Cash $309M · Debt $37M

ClearOcean signal read

ClearOcean's model currently scores ALMS as a watchlist-level signal (5/10), based on the insider, fundamental and risk data above. This is a factual model output, not advice.

Sources & further reading

Primary filings: SEC EDGAR — ALMS Form 4
How ClearOcean reads insider activity

Last updated September 15, 2026.

ClearOcean is a software research tool, not an investment adviser or broker-dealer. This page aggregates public data (incl. SEC filings) for informational purposes only — it is not investment advice, nor a recommendation, offer or solicitation to buy or sell any security. Past activity does not predict future results. You are solely responsible for your decisions; investing can lose value, up to total loss of capital.